Added to YB: 2025-02-26
Pitch date: 2025-02-24
LNSR [bullish]
LENSAR, Inc.
+38.27%
current return
Author Info
Company Info
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.
Market Cap
$163.0M
Pitch Price
$9.25
Price Target
N/A
Dividend
N/A
Sector
Health Care Equipment and Supplies
Category
growth
LNSR: LENSAR Upside Into Global Clearance Looks Compelling
LNSR: ALLY cataract system driving record sales, 20% US market share, 4% quarterly install growth. High-margin recurring revenue from procedures. New Taiwan/EU clearances. Breakeven Adj. EBITDA, positive FCF, no debt, 17% cash/mkt cap. Potential to double in 3 years with international expansion. Earnings 2/27 pre-market.
Read full article (12 min)